ResearcherNew York UniversityActive in the last 2 years

Xiaofei Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-0810-7254; OpenAlex author ID A5146586870. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2026: 1 paper

Papers 1

Neoadjuvant Therapy-Induced Remodeling in Pancreatic Ductal Adenocarcinoma: Multimodal Spatial Analysis and Prognosis. Co-author DOI 10.1111/cas.70320 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yao‐Zhong Liu · 1 shared paper, 2026 · strength 0.24
- Paper Neoadjuvant Therapy-Induced Remodeling in Pancreatic Ductal Adenocarcinoma: Multimodal Spatial Analysis and Prognosis. DOI 10.1111/cas.70320 ↗
Michael Shusterman · 1 shared paper, 2026 · strength 0.24
- Paper Neoadjuvant Therapy-Induced Remodeling in Pancreatic Ductal Adenocarcinoma: Multimodal Spatial Analysis and Prognosis. DOI 10.1111/cas.70320 ↗
Jessica L. Widmer · 1 shared paper, 2026 · strength 0.24
- Paper Neoadjuvant Therapy-Induced Remodeling in Pancreatic Ductal Adenocarcinoma: Multimodal Spatial Analysis and Prognosis. DOI 10.1111/cas.70320 ↗
John Allendorf · 1 shared paper, 2026 · strength 0.24
- Paper Neoadjuvant Therapy-Induced Remodeling in Pancreatic Ductal Adenocarcinoma: Multimodal Spatial Analysis and Prognosis. DOI 10.1111/cas.70320 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.